Beijing Beilu Pharmaceutical (300016.SZ): Contrast agent production line passes EU GMP certification.

Beijing Beilu Pharmaceutical (300016.SZ) announced that recently, the company has received a "Drug GMP Certificate" issued by the Dutch Medicines Authority in accordance with relevant regulations of the European Medicines Agency, certifying the production line of terminal sterilized injections. According to the EU GMP mutual recognition system among member states, obtaining the GMP certification indicates that the contrast agent production line that has been certified meets the EU GMP standards, creating conditions for the company to export contrast agent products to regulated markets such as the EU. This will be beneficial for the company to further expand into overseas markets, enhance the international market competitiveness of the company's contrast agent products, and positively impact the company's operations in the future.